{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:52:33Z","timestamp":1790211153826,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"am","delay-in-days":87,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1254238 CBET"],"award-info":[{"award-number":["1254238 CBET"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007709","name":"Michigan State University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007709","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Biotechnology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.copbio.2019.01.015","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T17:52:57Z","timestamp":1551203577000},"page":"104-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Data-driven engineering of protein therapeutics"],"prefix":"10.1016","volume":"60","author":[{"given":"Matthew S","family":"Faber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A","family":"Whitehead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.copbio.2019.01.015_bib0005","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a023812","article-title":"Synthetic DNA synthesis and assembly: putting the synthetic in synthetic biology","volume":"9","author":"Hughes","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.copbio.2019.01.015_sbref0010","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1126\/science.aan0693","article-title":"Global analysis of protein folding using massively parallel design, synthesis, and testing","volume":"357","author":"Rocklin","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.copbio.2019.01.015_bib0015","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.sbi.2016.11.001","article-title":"Deep sequencing methods for protein engineering and design","volume":"45","author":"Wrenbeck","year":"2017","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.copbio.2019.01.015_bib0020","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.tibtech.2016.09.010","article-title":"Advanced methodologies in high-throughput sequencing of immune repertoires","volume":"35","author":"Friedensohn","year":"2017","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.copbio.2019.01.015_bib0025","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.tibtech.2018.05.008","article-title":"Evaluating and mitigating the immunogenicity of therapeutic proteins","volume":"36","author":"Sauna","year":"2018","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.copbio.2019.01.015_bib0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bej.2018.06.003","article-title":"Understanding and overcoming trade-offs between antibody affinity, specificity, stability and solubility","volume":"137","author":"Rabia","year":"2018","journal-title":"Biochem Eng J"},{"key":"10.1016\/j.copbio.2019.01.015_bib0035","series-title":"Directed Enzyme Evolution: Advances and Applications","first-page":"17","article-title":"Engineering therapeutic enzymes","author":"Lutz","year":"2017"},{"key":"10.1016\/j.copbio.2019.01.015_bib0040","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/nmeth.4029","article-title":"Plasmid-based one-pot saturation mutagenesis","volume":"13","author":"Wrenbeck","year":"2016","journal-title":"Nat Methods"},{"key":"10.1016\/j.copbio.2019.01.015_bib0045","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1126\/science.1251152","article-title":"Restoring systemic GDF11 levels reverses age-related dysfunction in mouse skeletal muscle","volume":"344","author":"Sinha","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.copbio.2019.01.015_bib0050","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cmet.2015.05.010","article-title":"GDF11 increases with age and inhibits skeletal muscle regeneration","volume":"22","author":"Egerman","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.copbio.2019.01.015_bib0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-213X-9-24","article-title":"Redundancy of myostatin and growth\/differentiation factor 11 function","volume":"9","author":"McPherron","year":"2009","journal-title":"BMC Dev Bio"},{"key":"10.1016\/j.copbio.2019.01.015_bib0060","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1124\/mol.63.6.1256","article-title":"The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints","volume":"63","author":"Fredriksson","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.copbio.2019.01.015_bib0065","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1073\/pnas.95.2.548","article-title":"Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)","volume":"95","author":"Achen","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.copbio.2019.01.015_bib0070","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.cytogfr.2004.03.007","article-title":"The PDGF family: four gene products form five dimeric isoforms","volume":"15","author":"Fredriksson","year":"2004","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.copbio.2019.01.015_bib0075","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nbt.2214","article-title":"Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing","volume":"30","author":"Whitehead","year":"2012","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.copbio.2019.01.015_bib0080","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/19420862.2017.1337618","article-title":"Tuning the specificity of a two-in-one fab against three angiogenic antigens by fully utilizing the information of deep mutational scanning","volume":"6","author":"Koenig","year":"2017","journal-title":"MAbs"},{"key":"10.1016\/j.copbio.2019.01.015_bib0085","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/protein\/gzv029","article-title":"Directed evolution of anti-HER2 DARPins by SNAP display reveals stability\/function trade-offs in the selection process","volume":"28","author":"Houlihan","year":"2015","journal-title":"Protein Eng Des Sel"},{"key":"10.1016\/j.copbio.2019.01.015_sbref0090","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1073\/pnas.1616408114","article-title":"Biophysical properties of the clinical-stage antibody landscape","volume":"114","author":"Jain","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.copbio.2019.01.015_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005409","article-title":"A computationally designed hemagglutinin stem-binding protein provides in vivo protection from influenza independent of a host immune response","volume":"12","author":"Koday","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.copbio.2019.01.015_bib0100","doi-asserted-by":"crossref","DOI":"10.1038\/srep45259","article-title":"Efficient affinity maturation of antibody variable domains requires co-selection of compensatory mutations to maintain thermodynamic stability","volume":"7","author":"Julian","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.copbio.2019.01.015_sbref0105","doi-asserted-by":"crossref","first-page":"E486","DOI":"10.1073\/pnas.1613231114","article-title":"Mutational landscape of antibody variable domains reveals a switch modulating the interdomain conformational dynamics and antigen binding","volume":"114","author":"Koenig","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.copbio.2019.01.015_bib0110","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nbt.4180","article-title":"Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzyme","volume":"36","author":"Triplett","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.copbio.2019.01.015_bib0115","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature25465","article-title":"Asparagine bioavailability governs metastasis in a model of breast cancer","volume":"554","author":"Knott","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.copbio.2019.01.015_bib0120","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1136\/jmedgenet-2014-102797","article-title":"Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease","volume":"52","author":"Germain","year":"2015","journal-title":"J Med Genet"},{"key":"10.1016\/j.copbio.2019.01.015_sbref0125","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1073\/pnas.1614437114","article-title":"Trade-offs between enzyme fitness and solubility illuminated by deep mutational scanning","volume":"114","author":"Klesmith","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.copbio.2019.01.015_bib0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147596","article-title":"Kinetic characterization of 100 glycoside hydrolase mutants enables the discovery of structural features correlated with kinetic constants","volume":"11","author":"Carlin","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.copbio.2019.01.015_bib0135","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1074\/jbc.RA117.000948","article-title":"Structural and mechanistic analysis of a \u03b2-glycoside phosphorylase identified by screening a metagenomic library","volume":"293","author":"Macdonald","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.copbio.2019.01.015_bib0140","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1126\/science.356.6339.673","article-title":"Genome writing project confronts technology hurdles","volume":"356","author":"Servick","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.copbio.2019.01.015_bib0145","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tibtech.2018.05.014","article-title":"The increasingly human and profitable monoclonal antibody market","volume":"37","author":"Grilo","year":"2018","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.copbio.2019.01.015_bib0150","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead-and drug-like compounds: the rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov Today Technol"},{"key":"10.1016\/j.copbio.2019.01.015_bib0155","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1021\/acs.molpharmaceut.7b00779","article-title":"Biophysical and sequence-based methods for identifying monovalent and bivalent antibodies with high colloidal stability","volume":"15","author":"Alam","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1016\/j.copbio.2019.01.015_bib0160","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1080\/19420862.2015.1016696","article-title":"Balancing charge in the complementarity-determining regions of humanized mAbs without affecting pI reduces non-specific binding and improves the pharmacokinetics","volume":"7","author":"Datta-Mannan","year":"2015","journal-title":"MAbs"},{"key":"10.1016\/j.copbio.2019.01.015_bib0165","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature23912","article-title":"Massively parallel de novo protein design for targeted therapeutics","volume":"550","author":"Chevalier","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.copbio.2019.01.015_bib0170","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1126\/science.aao5167","article-title":"Multiplexed gene synthesis in emulsions for exploring protein functional landscapes","volume":"359","author":"Plesa","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.copbio.2019.01.015_bib0175","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0167-4838(00)00238-7","article-title":"The consensus concept for thermostability engineering of proteins","volume":"1543","author":"Lehmann","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.copbio.2019.01.015_bib0180","doi-asserted-by":"crossref","first-page":"17664","DOI":"10.1074\/jbc.M116.728485","article-title":"Design and characterization of Erwinia Chrysanthemi l-asparaginase variants with diminished l-glutaminase activity","volume":"291","author":"Nguyen","year":"2016","journal-title":"J Biol Chem"},{"key":"10.1016\/j.copbio.2019.01.015_bib0185","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.biortech.2017.05.057","article-title":"Genetic and metabolic engineering approaches for the production and delivery of l-asparaginases: an overview","volume":"245","author":"Vidya","year":"2017","journal-title":"Bioresour Technol"},{"key":"10.1016\/j.copbio.2019.01.015_bib0190","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1158\/0008-5472.CAN-17-2106","article-title":"A novel l-asparaginase with low l-glutaminase coactivity is highly efficacious against both T and B cell acute lymphoblastic leukemias in vivo","volume":"6","author":"Nguyen","year":"2018","journal-title":"Cancer Res"},{"key":"10.1016\/j.copbio.2019.01.015_bib0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1004556","article-title":"FireProt: energy-and evolution-based computational design of thermostable multiple-point mutants","volume":"11","author":"Bednar","year":"2015","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/j.copbio.2019.01.015_sbref0200","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.molcel.2016.06.012","article-title":"Automated structure-and sequence-based design of proteins for high bacterial expression and stability","volume":"63","author":"Goldenzweig","year":"2016","journal-title":"Mol Cell"},{"key":"10.1016\/j.copbio.2019.01.015_bib0205","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1093\/molbev\/msw138","article-title":"On the potential origins of the high stability of reconstructed ancestral proteins","volume":"33","author":"Trudeau","year":"2016","journal-title":"Mol Biol Evol"},{"key":"10.1016\/j.copbio.2019.01.015_bib0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nbt.3762","article-title":"Mining ancient proteins for next-generation drugs","volume":"35","author":"Lazarus","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.copbio.2019.01.015_bib0215","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.sbi.2018.02.007","article-title":"Biotechnological and protein-engineering implications of ancestral protein resurrection","volume":"51","author":"Risso","year":"2018","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.copbio.2019.01.015_bib0220","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1042\/BCJ20160532","article-title":"Engineering ancestral protein hyperstability","volume":"473","author":"Romero-Romero","year":"2016","journal-title":"Biochem J"},{"key":"10.1016\/j.copbio.2019.01.015_sbref0225","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nbt.3677","article-title":"Enhancing the pharmaceutical properties of protein drugs by ancestral sequence reconstruction","volume":"35","author":"Zakas","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.copbio.2019.01.015_bib0230","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/jth.12634","article-title":"Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa","volume":"12","author":"Lentz","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.copbio.2019.01.015_bib0235","doi-asserted-by":"crossref","first-page":"8614","DOI":"10.1073\/pnas.1709203114","article-title":"Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodies","volume":"114","author":"Hwang","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.copbio.2019.01.015_bib0240","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/nm.3743","article-title":"In-depth determination and analysis of the human paired heavy-and light-chain antibody repertoire","volume":"21","author":"DeKosky","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.copbio.2019.01.015_bib0245","doi-asserted-by":"crossref","first-page":"E2636","DOI":"10.1073\/pnas.1525510113","article-title":"Large-scale sequence and structural comparisons of human naive and antigen-experienced antibody repertoires","volume":"113","author":"DeKosky","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.copbio.2019.01.015_bib0250","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1080\/19420862.2018.1426422","article-title":"A natively paired antibody library yields drug leads with higher sensitivity and specificity than a randomly paired antibody library","volume":"10","author":"Adler","year":"2018","journal-title":"MAbs"},{"key":"10.1016\/j.copbio.2019.01.015_bib0255","doi-asserted-by":"crossref","first-page":"537","DOI":"10.3389\/fimmu.2017.00537","article-title":"Gene-specific substitution profiles describe the types and frequencies of amino acid changes during antibody somatic hypermutation","volume":"8","author":"Sheng","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.copbio.2019.01.015_bib0260","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4049\/jimmunol.1800708","article-title":"Observed antibody space: a resource for data mining next generation sequencing antibody repertoires","volume":"201","author":"Kovaltsuk","year":"2018","journal-title":"J Immunol"}],"container-title":["Current Opinion in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166918301587?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166918301587?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:07:04Z","timestamp":1760692024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958166918301587"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":52,"alternative-id":["S0958166918301587"],"URL":"https:\/\/doi.org\/10.1016\/j.copbio.2019.01.015","relation":{},"ISSN":["0958-1669"],"issn-type":[{"value":"0958-1669","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Data-driven engineering of protein therapeutics","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Biotechnology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.copbio.2019.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}